MARTINO, Sabata
 Distribuzione geografica
Continente #
NA - Nord America 5.363
EU - Europa 4.525
AS - Asia 1.558
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 11.467
Nazione #
US - Stati Uniti d'America 5.197
IE - Irlanda 923
UA - Ucraina 917
IT - Italia 700
SG - Singapore 582
SE - Svezia 505
HK - Hong Kong 433
DE - Germania 355
FI - Finlandia 257
VN - Vietnam 250
FR - Francia 249
RU - Federazione Russa 226
GB - Regno Unito 222
CN - Cina 192
CA - Canada 159
CH - Svizzera 42
TR - Turchia 35
CZ - Repubblica Ceca 28
KR - Corea 25
NL - Olanda 22
BE - Belgio 20
PL - Polonia 17
AT - Austria 16
UZ - Uzbekistan 14
JP - Giappone 12
LB - Libano 10
EU - Europa 7
MX - Messico 7
GR - Grecia 6
DK - Danimarca 5
AU - Australia 3
BG - Bulgaria 3
CO - Colombia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ES - Italia 2
ID - Indonesia 2
NO - Norvegia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
HU - Ungheria 1
IR - Iran 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.467
Città #
Chandler 1.018
Dublin 923
Jacksonville 507
San Mateo 495
Singapore 449
Hong Kong 426
Boardman 321
Perugia 301
Santa Clara 251
Dong Ket 250
Medford 228
Princeton 227
Wilmington 172
Montréal 150
Ann Arbor 139
Altamura 138
Munich 120
Lawrence 112
Andover 108
Ashburn 105
Beijing 99
Mcallen 86
Des Moines 82
Saint Petersburg 72
Helsinki 60
Norwalk 51
Shanghai 42
Izmir 33
Woodbridge 33
Los Angeles 29
Redmond 27
Seoul 25
Philadelphia 24
Brno 23
Rome 22
San Paolo di Civitate 22
New York 21
Auburn Hills 19
Redwood City 19
Brussels 17
Falls Church 16
Moscow 14
San Diego 14
Città Di Castello 13
Dallas 12
Den Haag 11
Houston 10
London 10
Cambridge 9
Milan 9
Lausanne 8
Florence 7
Paris 7
Terni 7
Fairfield 6
Gubbio 6
Simi Valley 6
Vienna 6
Bromley 5
Central 5
Dearborn 5
Detroit 5
Tokyo 5
Amsterdam 4
Assisi 4
Chicago 4
Desio 4
Egham 4
Frankfurt Am Main 4
Guangzhou 4
Lincoln 4
Mexico City 4
Nanjing 4
Sesto Fiorentino 4
Toronto 4
Windsor 4
York 4
Arlington 3
Bogotá 3
Boston 3
Concord 3
Copenhagen 3
Crewe 3
Espoo 3
Esslingen am Neckar 3
Fremont 3
Gustavo Adolfo Madero 3
Higashiikebukuro 3
Kazan' 3
Nuremberg 3
Piediluco 3
Renton 3
Rotterdam 3
Stockholm 3
Tama 3
Zurich 3
Abidjan 2
Alexandria 2
Anchorage 2
Bristol 2
Totale 7.563
Nome #
Nanostructured Biopolymer-based Materials for Regenerative Medicine Applications 475
Keratins extracted from Merino wool and Brown Alpaca fibres: thermal, mechanical and biological properties of PLLA based biocomposites 111
Carbon nanotubes and silver nanoparticles for multifunctional conductive polymer composites 99
Tuning Stem Cells Fate by PLLA-based materials: A Matter of Mechanotransduction. 98
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 95
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 89
Caspase 3 mediated PARP cleavage in lymphocytes from newborn babies of diabetic mothers 89
Intracerebral gene therapy in children with metachromatic leukodystrophy: Results of a phase I/II trial 89
Cellule staminali e GM2 gangliosidosi 88
Influence of cell differentiation and protein kinase C activation on sub-cellular distribution of beta-N-acetylhexosaminidases of HL 60 cells. 86
Adult neural stem cells as a tool for gehe therapy of Tay-Sachs disease 83
Implication of Cathepsins S and D in TPO+IL-16-induced commitment of hematopoietic stem cell differentiation into tolerogenic dendritic cells 82
Adipose stem cell translational applications: From bench-to-bedside 82
Restoration of hexosaminidase A activity and GM2 ganglioside metabolism in cells from patients with Tay-Sachs Disease 80
Expression of human a-subunit gene in the central nervous system of the Tay-Sachs animal model 80
Human bone marrow mesenchymal stem cell guidance by a-C:H surface designes 80
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 80
Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients 80
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 79
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 78
Approcci di terapia genica per le malattie da accumulo metabolico lisosomiale con coinvolgimento neurologico 77
a-C:H NANOPATTERNED FILM DESIGNS DRIVE HUMAN BONE MARROW MESENCHYMAL STEM CELL CYTOSKELETON ARCHITECTURE 77
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 77
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells 76
b-Hexosaminidase and altered cell-mediated immuno-responce 74
Absence of metabolic cross-correction in tay-sachs cells: implication in gene therapy 74
Hydrogenated Amorphous Carbon Nanopatterned Film Designs Drive Human Bone Marrow Mesenchymal Stem Cell Cytoskeleton Architecture 74
Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases 71
Protein Encapsulation in Biodegradable Polymeric Nanoparticles: Morphology, Fluorescence Behaviour and Stem Cell Uptake 71
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 71
Sistemi di "Drug delivery di B-esosaminidasi nella mallattia di Tay-Sachs 69
Acid glycohydrolases activities in linphomonocytes plasma-membrane of patients with multiple sclerosis 69
a-C:H nanopatterned grooves influence human bone marrow stromal stem cells orientation 68
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 68
Proteomics and Epigenetic Mechanisms in Stem Cells 67
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 66
Analysis of galactocerebrosidase activity in the mouse brain by a-new hysological staining method 66
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 65
In vivo gene therapy approach using herpes simplex vector for Tay-Sachs disease 64
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 64
Integrated Computational Analysis Highlights unique miRNA Signatures in the Subventricular Zone and Striatum of GM2 Gangliosidosis Animal Models 64
Tuning multi pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats. 63
Adult neural stem cells as a tool for gene therapy for Tay-Sachs disease. 63
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 63
Localizzazione e caratterizzazione biochimica di forma di membrana nella b-n-acetilesosaminidase 62
Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models. 62
Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism asa potential novel metabolism in Chronic Lymphocytic Leukemia 62
Osteogenic Induction in human Bone Marrow mesenchymal Stem Cells by nonocomposite Scaffold 61
Stem cell-biomaterial interactions for regenerative medicine 61
Carbon nanotubes and silver nanoparticles for multifunctional conductive biopolymer composites 61
Efficient lentiviral vector-mediated delivery of hARSA in the brain of juvenile non-human primates 61
Efficacy of combined gene/cell therapy in a murine model of Globoid cell Leukodystrophy 61
Beta-Hexosaminidase and immuno-response: implications for the neurodegenerative process in GM2 gangliosidosis 60
B-hexosaminidase isoenzymes and antigen presenting cell function: implication for neurodegenerative process in GM2-gangliosidosis 60
ARSD as a new biomarker associated with IGVH, ZAP-70, and disease progression in CLL. 60
Biocompatible Poly(l-lactide)/MWCNT Nanocomposites: Morphological Characterization, Electrical Proprieties, and Stem Cell Interation. 60
The influence of modified silica nanomaterials on adult stem cell culture 60
Beta-Hexosaminidase expression is recapitulated in Neural Stem Cells induced to differentiate and in embryonic to adult brain development in both WT and knock-out mice 59
Effect of SWCNT introduction in random copolymers on material properties and fibroblast long term culture stability 59
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 59
Above the Epitranscriptome: RNA Modifications and Stem Cell Identity 59
Novel nanocomposite PLA films with lignin/zinc oxide hybrids: Design, characterization, interaction with mesenchymal stem cells 59
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 58
Beta-hexosaminidase and antigen presenting cell function: implication for neurodegenerative process in GM2 gangliosidosis. 58
Modulating protein adsorption onto biomaterials by surface plasma treatment-VI Convegno Nazionale sulla Scienza e Tecnologia dei Materiali 58
Regulation of neural stem cell compartment in a murine model of GM2-gangliosidosis: potential role of EGF and GM3 ganglioside 58
Nanocomposites Based on PLLA and Multi Walled Carbon Nanotubes Support the Myogenic Differentiation of Murine Myoblast Cell Line 58
Optimized bicistronic lentiviral vectors to correct beta-hexosaminidase deficiency in neural and hematopoietic stem/progenitor cells and progeny 58
Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis 58
Overcoming GALC toxicity in Hematopoietic Stem Cell gene therapy for Globoid cell leukodystrophy 57
STEM CELL NICHE AND LYSOSOMAL CATHEPSINS 57
Acid glycohydrolase activities in lymphomonocyte plasma- membranes of patients with multiple sclerosis 57
"Terapia delle malattie neurodegenerative con cellule staminali: overview sullo stato attuale" 56
Knock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells 56
Inclusion of multi walled carbon nanotubes on PLLA supports the myogenic differentiation of murine progenitor cells 56
Characterization and localization of plasma membrane B-N-acetylhexosaminidases 56
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy 56
The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers 56
Stem cell niche and lysosomal cathepsins 55
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement theraphy 55
Neural Stem Cell Gene Therapy Ameliorates Pathology And Function In A Mouse Model Of Globoid Cell Leukodystrophy 55
Human neural crest-derived postnatal cells exhibit remarkable embryonic attributes either in vitro or in vivo. 55
Nano-engineered PLLA based biomaterial drives stem cell responses 55
Insight into mechanobiology: How stem cells feel mechanical forces and orchestrate biological functions 55
Le cellule staminali per la terapia delle GM2 gangliosidosi 54
Mechanotransduction: Tuning Stem Cells Fate 54
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 54
Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy 54
MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM CELLS TOWARDS NEURONAL DIFFERENTIATION 54
MicroRNAs and Molecular Mechanisms of Neurodegeneration 54
The role of physical cues in the development of stem cell-derived organoids 54
Le cellule staminali stromali di midollo osseo umane sono orientate da nanotopografie di carbonio amorfo idrogenato 53
Microarray Gene Expression Signature Indicates ARSD As a New Marker Associated with Igvh Mutational Status, ZAP-70 and Disease Progression in CLL 53
MicroRNA mediated lysosomal enzymes down-regulation in cell of peripheral system from aAlzheimer's disease patients 53
Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells 53
Functionalized silica star-shaped nanoparticles and human mesenchymal stem cells: An in vitro model 53
Neural precursor cell cultures from GM2-gangliosidosis murine models recapitulate the biochemical hallmarks of the brain pathology 52
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 52
Ex-vivo tissues engineering modeling for reconstructive surgery using human adult adipose stem cells and polymeric nanostructured matrix 52
A New Analytical Bench Assay for the Determination of Arylsulfatase A Activity Toward Galactosyl-3-Sulfate Ceramide: Implication for Metachromatic Leukodystrophy Diagnosis 52
Totale 6.964
Categoria #
all - tutte 49.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020870 0 0 0 0 195 109 185 40 175 87 20 59
2020/20211.939 32 148 63 144 563 94 153 5 222 61 171 283
2021/20221.774 29 367 73 98 55 21 21 535 15 68 201 291
2022/20233.166 254 452 62 229 280 387 18 148 1.187 9 113 27
2023/20241.547 206 143 85 30 18 18 282 72 207 56 137 293
2024/20251.016 49 330 150 113 374 0 0 0 0 0 0 0
Totale 12.019